Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells
Open Access
- 1 January 2005
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 93 (04), 710-715
- https://doi.org/10.1160/th04-11-0720
Abstract
Protease activity promotes the progression and rupture of atherosclerotic plaques. LDL has been described to become enzymatically modified within the vessel wall yielding an atherogenic moiety (E-LDL). We studied the effect of E-LDL on the activation of plasminogen and matrix metalloproteinases (MMPs) in mono-cytes and vascular smooth muscle cells (VSMCs) as well as on MMP activation during cellular interactions. Human monocytes, monocytic MonoMac6 cells and human VSMCs were incubated with human native LDL (n-LDL) or E-LDL for 24 hours. E-LDL in contrast to n-LDL induced substantial activation of the plasminogen activation system as well as of the MMP system in monocytic cells, as measured by enhanced cell surface expression of the urokinase receptor (uPAR), the extracellular matrix metalloproteinase Inducer (EMMPRIN) and the membrane type-1 MMPs (MT1-MMP, MMP-14), as well as by secretion of active uPA, and of MMP-9. Consistently, E-LDL-treated monocytes exhibited increased transmigration through “matrigel”, which was specifically abrogated by the MMP inhibitor galardin or the plasmin inhibitor aprotinin. In VSMCs, E-LDL induced MMP-1 and MMP-2 secretion. Moreover, monocyte incubation with supernatants of E-LDL-treated (but not n-LDL-treated)VSMCs strongly induced MMP-9 in monoytes, which was inhibited by blocking mAb anti-TNF-α. Together, enzymatical modification of LDL allows a direct activation of MMP expression in monocytes and VSMCs, and indirectly promotes the induction of paracrine, cytokine-mediated intercellular activation processes. Thereby, E-LDL may contribute to atheroprogression, inflammation and plaque rupture.This publication has 29 references indexed in Scilit:
- Enzymatic Modification of Low-Density Lipoprotein in the Arterial WallArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cellsAtherosclerosis, 2004
- Possible Protective Role for C-Reactive Protein in AtherogenesisCirculation, 2004
- Beyond cholesterol: the enigma of atherosclerosis revisitedThrombosis and Haemostasis, 2004
- Enzymatically Modified LDL Induces Cathepsin H in Human MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarctionBlood, 2002
- Complement and AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Enzymatically Modified, Nonoxidized LDL Induces Selective Adhesion and Transmigration of Monocytes and T-Lymphocytes Through Human Endothelial Cell MonolayersArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Atherogenic Properties of Enzymatically Degraded LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989